Echo | Angio | ECG | X-Ray/MRI | Clinical Trials | Guidelines | Drug Info |  Journals  | Events | Interesting Cases

Welcome May 20, 2013
Search News by Date
  



Subjects with masked hypertension have an early alteration of diastolic dysfunction

Several studies have shown that subjects with masked hypertension (MHT) are at a higher risk of cardiovascular events than those with sustained normotension (NT).

In this backdrop, Dr. Oe Yukiko and coworkers performed the present study that evaluated whether masked hypertension was associated with reduced left ventricular (LV) diastolic function, compared with normotension and sustained hypertension (SHT).

Study population consisted of 798 subjects 59.2% females), without a history of CVD or treated hypertension, were enrolled in the ongoing Masked Hypertension Study (a worksite-based study of the prevalence, predictors, and prognosis of MHT) from February 2005 to December 2010.

As a part of study, all the enrollees underwent the following; 9 clinic BP measurements that were obtained over 3 office visits (3 readings per visit), 24-hour ambulatory BP measurement and two-dimensional echocardiograms including PW and Tissue Doppler. Mean SBP > 140 mmHg or mean DBP > 90 mmHg defined clinic hypertension. Mean SBP > 135 mmHg or mean DBP >85 mmHg defined ambulatory hypertension. Combinations of clinic and ambulatory BP defined MHT, SHT, and NT. 8 enrollees detected with white coat hypertensives (defined as having clinic hypertension and ambulatory normotension) were excluded from this analysis. 116 enrollees (14.5%) had MHT (clinic normotension and ambulatory hypertension), 37 (4.6%) had SHT (clinic and ambulatory hypertension), and 637 (80%) had NT (clinic and ambulatory normotension).

Findings from this analysis showed differences among echocardiographic measures that included diastolic function between MHT and NT; and between SHT and NT in models adjusted for age, sex, race and body mass index (table)

Table: Differences among echocardiographic measures

 

Mean(95% CI) P-values
MHT SHT NT MHT vs. NT SHT vs. NT
E’-velocity(m/s) 0.121 (0.114-0.127) 0.116(0.105-0.127) 0.131(0.128-0.134) <0.01 <0.05
E/E’ ratio 6.2(5.88-6.51) 6.57(6.01-7.14) 5.71(5.58-5.84) <0.05 0.01
Fractional shortening (%) 33.4(32.1-34.8) 37(34.6-39.4) 32.8(32.2-33.4) 0.63 <0.005
Left ventricular mass(g) 122(116-127) 134(125-143) 116(114-119) 0.18 <0.005
Left ventricular mass index 64.0(61.5-66.6) 696(65.1-74.1) 61.8(60.7-62.8) 0.24 0.003
Relative wall thickness 36.2(34.6-37.9) 43(40-46) 35.3(34.6-36) 0.55 <0.005

In conclusion this study indicated that reduced diastolic function was reported in subjects with masked hypertension when compared to normotensives in the absence of left ventricular structural and systolic function changes, which was suggestive of an early alteration of diastolic dysfunction in subjects with masked hypertension.

 


Source:ASH 2012
Compiled and edited by the Editorial team and approved by Expert panel of CardioValens.com

 Other News
First study to evaluate the effectiveness of Functional Electrical Stimulation on exercise capacity, endothelial function and echocardiographic indices of diastolic function in chronic heart failure patients with preserved systolic function
Higher predictive value for malignant ventricular arrhythmias and complex end point for patients with dilated nonischaemic cardiomyopathy and chronic heart failure
Association between hyperglycemia and adverse outcomes observed in AMI patients does not hold true in patients hospitalized with other cardiovascular conditions
Presence of septal asymmetric Hypertrophic cardiomyopathy type is the only independent predictor of increased right atrial volume index
Excellent post-transplant outcomes with mechanical circulatory support as bridge to heart transplantation
Significantly decreased degree of mitral regurgitation or an improved mitral regurgitation, reverse remodeling of left atrium and decrease in left atrium diameters are the benefits with cardiac resynchronization therapy
Myocardial lipid content correlates inversely with left ventricular function in heart failure patients with type 2 diabetes
Periodic use of levosimendan in outpatients with end-stage chronic heart failure is safe and effective in improving quality of life and in reducing re-admissions for worsening heart failure at least in the first eight months of therapy
Highly prevalent severe interatrial mechanical delay in heart failure with preserved ejection fraction is associated with shorter mitral A wave and higher filling pressures
Presence of microalbuminuria is a potential risk marker of events in patients admitted with ACS
The CARILLION® Mitral Contour System implanted in heart failure patients with functional mitral regurgitation provide clinical improvements
Digoxin in high risk Heart Failure patients with reduced ejection fractions
Co-relation between blood pressure/body composition and exercise in hypertensive older overweight individuals
Gender wise analysis of hypertensive patients under a stabilized therapy and without a history of cardiovascular events shows significant differences in the prediction of either stroke or global cardiovascular events or even both
Hygia Project: ingestion of full doses of hypertension medications at bedtime is a proper chronotherapeutic approach and shown to result in improved ambulatory BP control and fewer cardiovascular events
ARB-based aggressive antihypertensive therapy guided by home BP monitoring in patients with diabetes/pre-diabetes is effective in improving cardiovascular target damage
Hypoadiponectinemia and high aldosterone levels in arterial rigidity are responsible for resistance to an antihypertensive therapy
Total cholesterol control can be predicted by only younger age for management of childhood dyslipidemia and hypertension and prevention
Impact of the Combination Antihypertensive Therapy with inclusion of Atorvastatin and Metformin on insulin resistance parameters in patients with the metabolic syndrome and fasting hyperinsulinemia
The combination treatment with Telmisartan, Torasemid and Atorvastatin has positive effects on blood pressure levels and reduces the intensity of heart failure progression in hypertensive's with heart failure class II-III NYHA
Associations of an increasing plasma insulin levels in patients with metabolic syndrome and post-infarction cardio-sclerosis
Reflected pressure waves in the arm in contrast to central systolic BP do not contribute to the measured arm cuff systolic BP measurements except in Stage 2 hypertension and thereby do not typically influence the diagnosis or staging of systolic hypertension

About Us | Disclaimer |  Privacy Statement | Advertising Info 
info@centrixhealthcare.com © Copyright 2000-2013 Centrix Healthcare Inc. - All Rights Reserved.